ABOS
Acumen Pharmaceuticals Inc
2.70$
+3.1%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | -15.4% | +0.0% | -100.0% | – | – | – | |
| – | -6.8% | +53.9% | -98.6% | +24,940.2% | -99.6% | +3.4% | |
| – | – | – | – | – | – | – | |
| – | -6.8% | +53.9% | +163.0% | +30.8% | +121.7% | +11.8% | |
| – | +45.9% | +438.8% | +76.9% | +46.2% | +7.4% | -6.3% | |
| – | +45.9% | +438.8% | +521.5% | +35.2% | +86.5% | +8.6% | |
| – | – | – | – | – | – | – | |
| – | – | – | -97.1% | -75.6% | +600.2% | +3.8% | |
| – | – | – | – | – | – | – | |
| – | – | – | -102.9% | – | – | – | |
| – | – | – | – | – | – | – | |
| – | -6,748.7% | – | – | – | – | – |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.